EugeneAhnMD

Oncology • Zion, IL

Breast Cancer, Genitourinary Oncology, Complementary and Integrative

Associate Clinical Professor, Department of Medical Oncology, & Therapeutics Research, City of Hope

Join to view full profile

Dr. Ahn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Ahn's full profile

Already have an account?

Office
2520 Elisha Avenue
Zion, IL 60099
Phone+1 847-748-0627
Is this information wrong?

Education & Training

University of Miami/Jackson Health SystemFellowship, Infectious Disease, 2000 - 2003
University of Utah HealthResidency, Internal Medicine, 1997 - 2000
University of Miami Leonard M. Miller School of MedicineClass of 1997

Certifications & Licensure

IL State Medical License 2014 - 2026
IA State Medical License 2020 - 2023
FL State Medical License 2004 - 2015
UT State Medical License 1998 - 2000
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Clinical Trials

Trastuzumab in Treating Older Women With Early-Stage Breast Cancer Start of enrollment: 2008 Nov 11
Completed
Phase 2
NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer Start of enrollment: 2016 Apr 01
Unknown status
Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer Start of enrollment: 2016 Mar 14
Recruiting
Phase 2

Publications & Presentations

PubMed

4 citations
Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study.
Herbert L Duvivier, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Eugene R Ahn, Tareq Al Baghdadi, Ajjai S Alva, Stephanie A Dublis, Timothy L Cannon, Carmen J...> ;Journal of Clinical Oncology. 2023 Nov 20
3 citations
Pertuzumab Plus Trastuzumab in Patients With Lung Cancer WithMutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study.
Apar K Ganti, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Elie G Dib, Herbert L Duvivier, Eugene R Ahn, Deepti Behl, Hossein Borghaei, Ani S Balmanoukian, An...> ;JCO Precision Oncology. 2023 Jun 1
5 citations
Pertuzumab Plus Trastuzumab in Patients With Endometrial Cancer WithAmplification, Overexpression, or Mutation: Results From the TAPUR Study.
Eugene R Ahn, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Hussein M Ali-Ahmad, John Chan, Michael L Maitland, Sapna R Patel, Zachary Reese, Ani S Balmanoukia...> ;JCO Precision Oncology. 2023 Apr 1
6 citations
Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer WithMutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Kelsey A Klute, Michael Rothe, Elizabeth Garrett-Mayer, Pam K Mangat, Reza Nazemzadeh, Kathleen J Yost, Herbert L Duvivier, Eugene R Ahn, Timothy L Cannon, Olatunji B ...> ;JCO Precision Oncology. 2022 Nov 1
11 citations
Pertuzumab Plus Trastuzumab in Patients With Colorectal Cancer WithAmplification orMutations: Results From the TAPUR Study.
Ranju Gupta, Funda Meric-Bernstam, Michael Rothe, Elizabeth Garrett-Mayer, Pam K Mangat, Stacy D'Andre, Eugene R Ahn, Raegan O'Lone, Susan Halabi, Gina N Grantham, Ric...> ;JCO Precision Oncology. 2022 Oct 1
30 citations
Survival of patients with de-novo metastatic breast cancer: analysis of data from a large breast cancer-specific private practice, a university-based cancer center and...
Simon B. Zeichner, Stuart Herna, Aruna Mani, Tadeu Ambros, Alberto J. Montero, Reshma Mahtani, Eugene R. Ahn, Charles L. Vogel> ;Breast Cancer Research and Treatment. 2015 Sep 10
13 citations
Defining the Survival Benchmark for Breast Cancer Patients with Systemic Relapse
Simon B. Zeichner, Tadeu Ambros, John Zaravinos, Alberto J. Montero, Reshma Mahtani, Eugene R. Ahn, Aruna Mani, Nathan J. Markward, Charles L. Vogel> ;Breast Cancer. 2015 Apr 15
56 citations
Improved Clinical Outcomes Associated With Vitamin D Supplementation During Adjuvant Chemotherapy in Patients With HER2+ Nonmetastatic Breast Cancer
Simon B. Zeichner, Tulay Koru-Sengul, Nikesh N. Shah, Qingyun Liu, Nathan J. Markward, Alberto J. Montero, Stefan Glück, Orlando Silva, Eugene R. Ahn> ;Clinical Breast Cancer. 2015 Feb 1
10 citations
A retrospective study evaluating a fixed low dose capecitabine monotherapy in women with HER-2 negative metastatic breast cancer.
Tadeu Ambros, Simon B. Zeichner, John Zaravinos, Alberto J. Montero, Eugene Ahn, Mani Aruna, Lori Kronish, Reshma Mahtani, Charles L. Vogel> ;Breast Cancer Research and Treatment. 2014 Jun 5
9 citations
Is the Improved Efficacy of Trastuzumab and Lapatinib Combination Worth the Added Toxicity? A Discussion of Current Evidence, Recommendations, and Ethical Issues Regar...
Eugene R. Ahn, Emilie Wang, Stefan Glück> ;Breast Cancer. 2012 Nov 19
41 citations
Dual HER2-targeted approaches in HER2-positive breast cancer
Eugene R. Ahn, Charles L. Vogel> ;Breast Cancer Research and Treatment. 2012 Jan 1
4 citations
Danazol therapy combined with intermittent application of chemotherapy induces lasting remission in myeloproliferative disorder (MPD): an alternative for the elderly w...
Vincenzo Fontana, Pamela Dudkiewicz, Eugene R. Ahn, Lawrence L. Horstman, Yeon S. Ahn> ;Hematology. 2011 Mar 1
54 citations
Increased procoagulant cell-derived microparticles (C-MP) in splenectomized patients with ITP
Vincenzo Fontana, W. Jy, Eugene R. Ahn, Pamela Dudkiewicz, Lawrence L. Horstman, Robert C. Duncan, Yeon-Soong Ahn> ;Thrombosis Research. 2008 Jan 1
6 citations
Oxaliplatin and Fixed-Rate Infusional Gemcitabine in the Second-Line Treatment of Patients with Metastatic Colon Cancer: Final Results of a Phase II Trial Prematurely ...
Gilberto Lopes, Jose Quesada, Eugene Ahn, Aurea M. Flores, Afonso Ribeiro, Caio Rocha-Lima> ;Clinical Colorectal Cancer. 2007 Sep 1
10 citations
Interstitial lung disease (ILD) and severe ITP.
Vincenzo Fontana, Lawrence L. Horstman, Elio Donna, Pamela Dudkiewicz, Eugene R. Ahn, Yeon S. Ahn> ;Hematology. 2007 Feb 1
25 citations
Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS).
Carlos J. Bidot, Wenche Jy, Lawrence L. Horstman, Eugene R. Ahn, Miriam Yaniz, Yeon S. Ahn> ;American Journal of Hematology. 2006 Jun 1
15 citations
The incidence of recurrent herpes simplex and herpes zoster infection during treatment with arsenic trioxide
Keyvan Nouri, Carlos Ricotti, Navid Bouzari, Halland Chen, Eugene R Ahn, Ardalan Bach> ;Journal of Drugs in Dermatology. 2006 Feb 1
32 citations
Platelet activation in Helicobacter pylori-associated idiopathic thrombocytopenic purpura: eradication reduces platelet activation but seldom improves platelet counts.
Eugene R. Ahn, Maike Tiede, Wenche Jy, Carlos J. Bidot, Vincenzo Fontana, Yeon S. Ahn> ;Acta Haematologica. 2006 Jan 1
9 citations
Antiphospholipid antibodies and platelet activation as risk factors for thrombosis in thrombocythaemia
Carlos J. Bidot, Wenche Jy, Lawrence L. Horstman, Eugene R. Ahn, Loreta Bidot, Vincenzo Fontana, Yeon S. Ahn> ;Hematology. 2005 Dec 1
15 citations
Life-threatening hypercoagulable state following splenectomy in ITP: successful management with aggressive antithrombotic therapy and danazol.
Maike Tiede, Eugene R. Ahn, Wenche Jy, Thomas Scagnelli, Carlos J. Bidot, Lawrence L. Horstman, Joaquin J. Jimenez, Yeon S. Ahn> ;Clinical and Applied Thrombosis/hemostasis. 2005 Jul 1
87 citations
Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation
Wenche Jy, J. J. Jimenez, Lucia M. Mauro, Lawrence L. Horstman, P. Cheng, Eugene R. Ahn, Carlos Bidot, Yeon S. Ahn> ;Journal of Thrombosis and Haemostasis. 2005 Jun 1
62 citations
Elevated endothelial microparticle—monocyte complexes induced by multiple sclerosis plasma and the inhibitory effects of interferon-β1b on release of endothelial micro...
Joaquin J. Jimenez, Wenche Jy, Lucia M. Mauro, Lawrence L. Horstman, Eugene R. Ahn, Yeon S. Ahn, Alireza Minagar> ;Multiple Sclerosis. 2005 Jun 1
36 citations
Correlation Between Apoptotic Endothelial Microparticles and Serum Interleukin-6 and C-Reactive Protein in Healthy Men
Julio A. Chirinos, Juan P. Zambrano, Salim S. Virani, Joaquin J. Jimenez, Wenche Jy, Eugene R. Ahn, Lawrence L. Horstman, Agustin Castellanos, Robert J. Myerburg, Yeon...> ;The American Journal of Cardiology. 2005 May 15
35 citations
Antiphospholipid antibodies in immune thrombocytopenic purpura tend to emerge in exacerbation and decline in remission.
Carlos J. Bidot, Wenche Jy, Lawrence L. Horstman, Eugene R. Ahn, Joaquin J. Jimenez, Miriam Yaniz, Gabriela Lander, Yeon S. Ahn> ;British Journal of Haematology. 2005 Feb 1
34 citations
Long-term remission from life-threatening hypercoagulable state associated with lupus anticoagulant (LA) following rituximab therapy.
Eugene R. Ahn, Gabriella Lander, Carlos J. Bidot, Wenche Jy, Yeon S. Ahn> ;American Journal of Hematology. 2005 Feb 1
Join now to see all

Lectures

Palbociclib (P) in patients (pts) with non-small cell lung cancer (NSCLC) with alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) ...
ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019

Press Mentions

RHSHC to Offer Oncology CareSeptember 29th, 2020
Positive Findings from Two TAPUR™ Study Cohorts to Be Presented at 2019 ASCO® Annual MeetingMay 22nd, 2019
4 Doctor-Approved Strategies to Live LongerMay 29th, 2017
Join now to see all